English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90453/105672 (86%)
Visitors : 13153039      Online Users : 631
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/112732


    Title: VEGF-C Gene Polymorphisms Increase Susceptibility to Rheumatoid Arthritis
    Authors: Da, Chengqian;Dai, Chengqian;Kuo, Shu-Jui;Kuo, Shu-Jui;Hu, Sung-Lin;Hu, Sung-Lin;Tsa, Chun-Hao;Tsai, Chun-Hao;黃元勵;HUANG, YUAN-LI;Chien-Chung;Huang, Chien-Chung;Wang, Lihong;Wang, Lihong;Xu, Guohong;Xu, Guohong;Su, Chen-Ming;Su, Chen-Ming;湯智昕;Chih-Hsin, Tang
    Contributors: 醫學檢驗暨生物技術學系
    Keywords: single nucleotide polymorphism, rheumatoid arthritis, VEGF-C
    Date: 2019-09
    Issue Date: 2020-08-27 14:33:18 (UTC+8)
    Publisher: 亞洲大學
    Abstract: Vascular endothelial growth factor C (VEGF-C) promotes angiogenesis, a prominent feature in rheumatoid synovitis, contributing to the perpetuation of the global burden of rheumatoid arthritis (RA). VEGF-C gene polymorphisms predict the risk of developing various human diseases, such as urothelial cell carcinoma, oral cancer and coronary artery disease. We sought to determine whether single nucleotide polymorphisms (SNPs) of the VEGF-C gene can predict the risk of RA. Our study recruited 210 patients with RA and 373 healthy controls between 2007 and 2015, and performed comparative genotyping for SNPs rs7664413, rs11947611, rs1485766, rs2046463 and rs3775194. In analyses adjusted for potential covariates, we found that compared with subjects with the A/A genotype of SNP rs11947611, those with the A/G genotype were 40% more likely to develop RA (adjusted odds ratio [AOR] 0.61; 95% confidence interval [CI] 0.40 to 0.92; p = 0.02). In addition, subjects lacking the A/A genotype (A/G, G/G) of SNP rs2046463 were more than twice as likely as those with the A/A genotype to require methotrexate (AOR 2.23, 95% CI 1.25 to 3.98; p = 0.01), while those who lacked the G/G genotype (G/C, C/C) in the SNP rs3775194 had a significantly lower risk of requiring prednisolone as compared with those with the G/G genotype (AOR 0.39, 95% CI 0.19 to 0.79; p = 0.01). Our findings suggest that VEGF-C gene polymorphisms might serve as a diagnostic marker and therapeutic target for RA therapy. Pharmacotherapies that modulate the activity of the VEGF-C gene may be promising for RA treatment.
    Relation: International Journal of Medical Sciences
    Appears in Collections:[醫學檢驗暨生物技術學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML21View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback